1. Home
  2. FSUN vs GLPG Comparison

FSUN vs GLPG Comparison

Compare FSUN & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$39.40

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$29.39

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
GLPG
Founded
1892
1999
Country
United States
Belgium
Employees
1186
704
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FSUN
GLPG
Price
$39.40
$29.39
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$45.33
$36.50
AVG Volume (30 Days)
253.8K
191.0K
Earning Date
04-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$79.34
N/A
Revenue Next Year
$14.67
N/A
P/E Ratio
$11.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.95
$24.74
52 Week High
$42.34
$37.78

Technical Indicators

Market Signals
Indicator
FSUN
GLPG
Relative Strength Index (RSI) 64.87 42.14
Support Level $37.45 $28.78
Resistance Level $40.24 $34.04
Average True Range (ATR) 1.40 0.64
MACD 0.35 0.15
Stochastic Oscillator 85.08 52.52

Price Performance

Historical Comparison
FSUN
GLPG

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments; Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: